Navigation Links
Pharmaceutical Strategic Initiatives Adds Anne Sexton, MD, MS to Management Team
Date:3/31/2008

DURHAM, N.C., March 31 /PRNewswire/ -- Pharmaceutical Strategic Initiatives (PSI), a provider of marketing consultation and content development services to the pharmaceutical industry, has added Anne L. Sexton MD, MS to its management team as Vice President of Medical Activities.

Dr. Sexton brings 15 years of clinical and pharmaceutical experience to PSI. Dr. Sexton's broad experience includes medical affairs and medical monitoring, drug development strategy, regulatory affairs activities including FDA submissions, drug safety/pharmacovigilance and medical writing.

According to PSI President Charles Carter, PhD, "Anne brings the clinical and industry experience our customers need to develop and implement their integrated medical affairs strategies and support regulatory initiatives."

Prior to joining PSI, Dr. Sexton headed an independent consulting company serving the pharmaceutical and biotech industries.

About Pharmaceutical Strategic Initiatives

PSI was founded in 1988 by Charles Carter, PharmD, MBA and is part of Interactive Holdings. PSI provides strategic marketing consultation and content development services to the pharmaceutical industry. For more information about PSI, contact Mary Messina at 919.314.1380 or visit http://www.psillc.com.


'/>"/>
SOURCE Pharmaceutical Strategic Initiatives
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
2. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
3. China Shenghuo Pharmaceutical Holdings, Inc. Schedules Conference Call to Discuss FY 2007 Results
4. Barr Pharmaceuticals, Inc. Executive Bios
5. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
6. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
7. Honeywell Expands Aclar(R) Production for Pharmaceutical Industry
8. Surveys Find Key Changes in the Role of the Pharmaceutical CFO
9. KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
10. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
11. MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... York (PRWEB) , ... December 05, 2016 , ... ... the ability of physical therapist assistants, under direct supervision of a licensed physical ... obtains physical therapy receives a consultation and treatment plan from a licensed physical ...
(Date:12/5/2016)... , ... December 05, 2016 , ... As renowned, board-certified ... the dangers and downsides of patients who do not do their research and undergo ... cosmetic dermatology is in the midst of a renaissance and every other month a ...
(Date:12/5/2016)... ... 2016 , ... Z-Medica, LLC, a leading developer and marketer ... College of Surgeons (ACS) to provide basic bleeding control instructor training to surgeons. ... is a pilot program that fulfills the intent of the White House’s “Stop ...
(Date:12/4/2016)... ... 03, 2016 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... New York City, with long-time partners The Paul Foundation, on November 10, 2016. ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... wins "Best Surgical Body Shaping" at the 2016 Anti-Aging & Beauty ... France. , The Aesthetic & Anti-Aging Medicine European Congress (AMEC) brings ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... December 2, 2016 According ... Diagnostics/IVD Market by Product (Instruments, Reagents, Software), Technology ... Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to ... valued at USD 60.22 Billion in 2016. This ... of 5.5% during the forecast period (2016-2021) to ...
(Date:12/2/2016)...  The Addiction Treatment Advisory Group (ATAG), created ... Pharmacy (AMCP), has released detailed findings on how ... addiction crisis, including through improved access to naloxone ... newly released paper, "The Role of Managed Care ... issues around gaps and barriers to addiction treatment ...
(Date:12/2/2016)... , Dec. 2, 2016 Boston Scientific ... definitive agreement to acquire certain manufacturing assets and capabilities ... (TSX: NVC) advanced biological tissue business, as well as ... of $75 million in cash. The Neovasc advanced biological ... including the Boston Scientific Lotus™ Valve System. * ...
Breaking Medicine Technology: